H3K9 Methylation Drives Resistance to Androgen Receptor–Antagonist Therapy in Prostate Cancer

Investigators showed that androgen blockade in prostate cancer leads to derepression of retroelements followed by a double-stranded RNA-stimulated interferon response that blocks tumor growth.